SouthState Corp’s NeoGenomics NEO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-98
Closed -$1.15K 1357
2025
Q4
$1.15K Hold
98
﹤0.01% 1092
2025
Q3
$757 Hold
98
﹤0.01% 1146
2025
Q2
$717 Hold
98
﹤0.01% 1348
2025
Q1
$931 Buy
+98
New +$1.22K ﹤0.01% 1355
2019
Q2
Sell
-19,835
Closed -$406K 270
2019
Q1
$406K Buy
+19,835
New +$345K 0.04% 203
2018
Q4
Sell
-21,109
Closed -$324K 260
2018
Q3
$324K Sell
21,109
-2,500
-11% -$34.6K 0.03% 218
2018
Q2
$309K Sell
23,609
-2,500
-10% -$27.5K 0.03% 223
2018
Q1
$213K Hold
26,109
0.02% 241
2017
Q4
$231K Buy
26,109
+1,109
+4% +$10.2K 0.02% 281
2017
Q3
$278K Hold
25,000
0.03% 211
2017
Q2
$224K Hold
25,000
0.03% 238
2017
Q1
$197K Hold
25,000
0.03% 243
2016
Q4
$214K Hold
25,000
0.03% 233
2016
Q3
$206K Hold
25,000
0.03% 223
2016
Q2
$201K Hold
25,000
0.03% 214
2016
Q1
$169K Sell
25,000
-15,976
-39% -$105K 0.03% 207
2015
Q4
$322K Buy
+40,976
New +$300K 0.05% 173

Other funds holding NEO

SouthState Corp's NEO Position: Q1 2026 in Review

SouthState Corp sold out of NeoGenomics (NEO) in Q1 2026, closing a stake of 98 shares — an estimated $1.15K sold.

SouthState Corp first reported a position in NEO in Q4 2015 and held it in 17 quarters. The position peaked at $406K in Q1 2019. 253 funds tracked by Wall St. Rank hold NEO as of Q1 2026.

  • SouthState Corp reported no remaining NeoGenomics position as of Q1 2026 after selling out during the quarter.
  • SouthState Corp sold 98 NeoGenomics shares in Q1 2026, an estimated $1.15K.
  • SouthState Corp first reported a position in NeoGenomics in Q4 2015 and held it in 17 quarters.
  • SouthState Corp's NeoGenomics position peaked at $406K in Q1 2019.
  • 253 funds tracked by Wall St. Rank held NeoGenomics as of Q1 2026.

Based on SouthState Corp's 13F filing for Q1 2026, filed 5 May 2026.